PRMT5 inhibitor (Nipuna Therapeutics/Prelude Therapeutics/Stanford University School of Medicine)

N/A

Report date: 2025/06/11 10:45:16
NME

Base Information

Drug NamePRMT5 inhibitor (Nipuna Therapeutics/Prelude Therapeutics/Stanford University School of Medicine)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionProtein arginine methyltransferase 5 inhibitors
TargetsProtein arginine methyltransferase 5
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStanford University School of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesNipuna Therapeutics IncStanford University School of MedicinePrelude Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A